Carisoprodol
Product Images NDC 55045-1433

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 55045-1433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 55045-1433-04 (Ndc 55045 1433 04 Qualitest)

Carisoprodol 350 mg tablet label from Dispensing Solutions, Inc., NDC 55045-1433-04. The label states 60 tablets per container, each containing 350 mg Carisoprodol USP. It includes usage warnings such as habit-forming potential, drowsiness, blurred vision, and alcohol avoidance. The label also displays lot number, expiration date, barcode, and manufacturer information with a caution to store at 68°-77°F and keep out of children's reach.*

FDA Label Image

This In An Image Of The Structural Formula Of Carisoprodol. (Carisoprodol 1)

Chemical structure of Carisoprodol, showing its molecular arrangement with carbon, hydrogen, nitrogen, and oxygen atoms connected to form the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.